Editorial
MicroRNAs and cholangiocarcinoma: elucidating the effects of tiny giants
AME Medical Journal
2018;
3:
98
(04 October 2018)
Editorial
Stressing the metabolic powers of fibroblast growth factor 21
AME Medical Journal
2018;
3:
97
(30 September 2018)
Editorial
Attempt to predict early recurrence of prostate cancer following prostatectomy through machine learning
AME Medical Journal
2018;
3:
96
(28 September 2018)
Editorial
Bile acid dependent and independent roles of fibroblast growth factor 15/19 in liver regeneration
AME Medical Journal
2018;
3:
95
(28 September 2018)
Editorial
Acute kidney injury in patients with decompensated cirrhosis: knowing the cause is often difficult
AME Medical Journal
2018;
3:
94
(27 September 2018)
Editorial
Prognostic factors during androgen deprivation therapy in patients with hormone naive metastatic prostate cancer: is changes in hemoglobin level significant?
AME Medical Journal
2018;
3:
92
(25 September 2018)
Editorial
Periprostatic adipose tissue interacts with prostate cancer to promote aggressive disease
AME Medical Journal
2018;
3:
91
(20 September 2018)
Letter to the Editor
Thrombophilia testing in mesenteric venous thrombosis, when to screen
AME Medical Journal
2018;
3:
90
(28 August 2018)
Editorial
Who can benefit from postoperative radiotherapy following biochemical recurrence after radical prostatectomy?—looking for the “Rosetta Stone” of prostate cancer
AME Medical Journal
2018;
3:
89
(24 August 2018)
Meet the Professor
Dr. Ghassan K. Abou-Alfa: iMDT is a precious and great channel for building relationships to learn from each other
AME Medical Journal
2018;
3:
88
(24 August 2018)
Case Report
Enucleation of schwannoma of the penis with neurovascular bundle sparing using the VTI 20 MHz Microvascular Doppler System
AME Medical Journal
2018;
3:
87
(23 August 2018)
Original Article
SABR/SBRT for oligometastatic cancer within NHS commissioning through evaluation program—a single centre experience
AME Medical Journal
2018;
3:
86
(23 August 2018)
Editorial
New genomic markers for improved decision making in the prostate cancer active surveillance era
AME Medical Journal
2018;
3:
85
(23 August 2018)
Editorial
The proton pump inhibitors use and gastric cancer development: is it a real association?
AME Medical Journal
2018;
3:
84
(23 August 2018)
iMDT Corner
Should red blood cell transfusion be immediately given to a cirrhotic patient with active upper gastrointestinal bleeding?
AME Medical Journal
2018;
3:
83
(16 August 2018)
Review Article
Bronchial thermoplasty: an update for the interventional pulmonologist
AME Medical Journal
2018;
3:
82
(14 August 2018)
Review Article
Minimally invasive persistent air leak management
AME Medical Journal
2018;
3:
80
(01 August 2018)
Original Article
Cardiovascular comorbidities in patients with chronic Chagas disease
AME Medical Journal
2018;
3:
79
(27 July 2018)
Letter to the Editor
Characteristics of peptic ulcer in military officers/soldiers: a preliminary analysis
AME Medical Journal
2018;
3:
78
(24 July 2018)
Preface
Toward a new era of holistic integrative medicine
AME Medical Journal
2018;
3:
77
(19 July 2018)
Review Article
Management of benign central airway obstruction
AME Medical Journal
2018;
3:
76
(19 July 2018)
Review Article
Foreign body removal in children and adults: review of available techniques and emerging technologies
AME Medical Journal
2018;
3:
75
(19 July 2018)
Review Article
Endobronchial ultrasound-guided-transbronchial needle injection for direct therapy of lung cancer
AME Medical Journal
2018;
3:
74
(17 July 2018)
Review Article
What is the role of transplantation in the management of alcoholic liver disease?
AME Medical Journal
2018;
3:
73
(06 July 2018)
Original Article
Elderly patients in Japan are susceptible to cervical spine injury: a database search study
AME Medical Journal
2018;
3:
72
(02 July 2018)
Editorial
Mutation burden: a limiting factor for personal cancer vaccines?
AME Medical Journal
2018;
3:
71
(29 June 2018)
Review Article
Endobronchial ultrasound bronchoscopy: current uses, innovations and future directions
AME Medical Journal
2018;
3:
70
(29 June 2018)
Editorial
Men on active surveillance without cancer on biopsy are less likely to reclassify
AME Medical Journal
2018;
3:
69
(26 June 2018)
Editorial
Circulating cell-free DNA is a potential prognostic biomarker of metastatic castration-resistant prostate cancer for taxane therapy
AME Medical Journal
2018;
3:
68
(21 June 2018)
Original Article
Prognostic significance of venous tumor thrombus consistency (solid vs. friable) in patients with renal cell carcinoma: A systematic review and meta-analysis
AME Medical Journal
2018;
3:
67
(14 June 2018)
Editorial
Does increased expression of glucocorticoid receptor support application of antagonists to this receptor for the treatment of castration resistant prostate cancer?
AME Medical Journal
2018;
3:
66
(13 June 2018)
Review Article
Introduction to Holistic Integrative Ophthalmology
AME Medical Journal
2018;
3:
65
(24 May 2018)
Editorial
Another step closer to unlocking specification of primordial germ cells
AME Medical Journal
2018;
3:
64
(10 May 2018)
Mini-Review
Blood pressure goals and patient-reported outcomes in patients with hypertension
AME Medical Journal
2018;
3:
63
(10 May 2018)
Editorial
Diagnostic heterogeneity in orthopaedic oncology makes standardized recommendations regarding anticoagulation difficult
AME Medical Journal
2018;
3:
62
(06 May 2018)
Original Article
Theoretical deposition of variably sized platelets in the respiratory tract of healthy adults
AME Medical Journal
2018;
3:
61
(06 May 2018)
Original Article
Single-institutions experience with acute kidney injury in the brain injury population
AME Medical Journal
2018;
3:
59
(23 April 2018)
Original Article
Relationship among biomarkers of iron metabolism and severity of underlying nonalcoholic steatohepatitis (NASH)
AME Medical Journal
2018;
3:
58
(20 April 2018)
Editorial
Application and approval of cancer drugs in China: acceleration should be kept in progress
AME Medical Journal
2018;
3:
57
(20 April 2018)
Editorial
Increased specialization in spine surgery and its implications on delivery and access to care in the United States Healthcare System
AME Medical Journal
2018;
3:
56
(13 April 2018)
Editorial
Abiraterone survival benefit is independent of pain, prostate-specific antigen and Gleason sum in men with chemo-naïve metastatic castration-resistant prostate cancer (analysis of COU-AA-302)
AME Medical Journal
2018;
3:
54
(04 April 2018)
Editorial
Fructosamine: a promising new risk stratification tool?
AME Medical Journal
2018;
3:
53
(04 April 2018)
Editorial
A nucleotide-binding oligomerization domain for innate immunity and reproduction
AME Medical Journal
2018;
3:
52
(03 April 2018)
Original Article
Metabolic inflammatory syndrome: a novel concept of holistic integrative medicine for management of metabolic diseases
AME Medical Journal
2018;
3:
51
(03 April 2018)
Review Article
Association between CYP17A1 polymorphisms and response to abiraterone in patients with metastatic castration-resistant prostate cancer: a systematic review
AME Medical Journal
2018;
3:
50
(03 April 2018)
Editorial
Comparison of pathological and oncologic outcomes in “favorable risk” GS 3+4 and low risk GS6 prostate cancer: considerations for active surveillance
AME Medical Journal
2018;
3:
49
(30 March 2018)